QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

NEW YORK, March 19 /PRNewswire/ — QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

   Autoimmune-Inflammation Index (HHA)   Drop    GW Pharmaceuticals, Inc     Human Genome Sciences     Ligand Pharmaceuticals, Inc.    Add    Fornix Biosciences N.V. (Amsterdam: FORBI.AS)    Meda AB (SHSE1: MEDA A)    Mitsubishi Tanabe Pharma Corporation     Cancer Index (HHK)   Drop    Shire PLC    Add    Ark Therapeutics Group Plc     Cardio Devices Index (HHE)   Drop    Biosphere Medical, Inc.    Add    Zoll Medical Corp.     Cardiology Index (HRD)   Drop    Encysive Pharmaceuticals, Inc.     Human Genome Sciences, Inc      Vical, Inc    Add    Mitsubishi Tanabe Pharma Corporation     Sangamo BioSciences Inc     Sciele Pharma, Inc.     Composite Index (HHQ)   Drop    Advanced Medical Optics, Inc.     Align Technology Inc.     Array Biopharma Inc.     ArthroCare Corp.     Endo Pharmaceuticals Hldgs.     Fresenius Medical Care AG (XETRA: FME.DE)    GEDEON RICHTER RT (XETRA: R1G1.DE)    GENMAB A/S (Copenhagen: GEN.CO)    H. LUNDBECK A/S (Copenhagen: LUN.CO)    Human Genome Sciences     Imclone Systems     Inverness Medical Innovations     Invitrogen Corp.     Medarex Inc.     Medicis Pharmaceutical     Mentor Corp.     ONYX Pharmaceuticals Inc.     PDL BioPharma, Inc.     Pharmion Corp.     Progenics Pharmaceuticals Inc.     Regeneron Pharmaceuticals     Respironics Inc.     Sepracor Inc.     Theravance Inc.     United Therapeutics Corp.     Valeant Pharmaceuticals Int’l     Vertex Pharmaceuticals    Add    Adolor Corp.     ALLOS THERAPEUTICS INC.     Alnylam Pharmaceuticals Inc.     Alpharma Inc.     Altus Pharmaceuticals Inc.     AMAG Pharmaceuticals Inc.     ANGIOTECH PHARMACEUTICALS     Ark Therapeutics     Bavarian Nordic A/S (Copenhagen: BAVA.CO)    Caraco Pharmaceutical Laboratories Ltd.     Cardiome Pharma Corp.     Coventry Health Care Inc.     CRUCELL-ADR     CUBIST PHARMACEUTICALS INC.     Discovery Laboratories Inc.     Eisai Co. Ltd.     Encysive Pharmaceuticals Inc.     Enzo Biochem Inc.     ENZON PHARMACEUTICALS INC.     Exelixis Inc.     Flamel Technologies     Illumina Inc.     Incyte Corporation     Integra LifeSciences Holdings     Meda AB (Stockholm: MEDAA.ST)    Mitsubishi Tanabe Pharma     Taisho Pharmaceutical Co., Ltd.      Dermatology and Wound Index (HRW)   Drop    Shire PLC (ADR)     SkyePharma Plc    Add    Standard Chemical & Pharm. Co., Ltd.     Taisho Pharmaceutical Co., Ltd.     Diagnostics Index (HHD)   Drop    CR Bard, Inc.     IDEXX Laboratories    Add    Bruker Corporation     Halozyme Therapeutic     Emerging Cancer Index (HHJ)   Drop    Adventrx Pharmaceuticals, Inc.     Keryx Biopharmaceuticals, Inc.    Add    Dyanvax Technologies     Synta Pharmaceuticals Corp.     Enabling Technologies Index (HHV)   Drop    Hillenbrand Industries    Add    Eurand N.V.      GI/Gender Index (HHU)   Drop    AEterna Zentaris     King Pharmaceuticals     Nastech Pharmaceutical    Add    Columbia Laboratories Inc.     Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)    Mylan, Inc.     Metabolic-Endocrine Disorders Index (HHM)   Drop    Depomed Inc.     Emisphere Technologies Inc.     Flamel Technologies SA ADS     Hospira Inc.     Human Genome Sciences, Inc.     Indevus Pharmaceuticals Inc.     Ipsen Ltd. (Paris: IPN.PR)    Nastech Pharmaceutical Co.     Nektar Therapeutics     NicOx S.A. (Paris: NCOX)    OSI Pharmaceuticals Inc.     ProStrakan Group Plc     Solvay S.A. (Brussels: SVYSY)   Add    Altus Pharmaceuticals Inc.     Amicus Therapeutics, Inc.     Biodel Inc.     CombinatoRx Inc.     GW Pharmaceuticals Plc     Incyte Corp.     Orexigen Therapeutics, Inc.     Repros Therapeutics Inc.     Sangamo BioSciences Inc.     Sirtris Pharmaceuticals, Inc.     SuperGen Inc.     Transition Therapeutics Inc.     XOMA Ltd.     Neuroscience Index (HHN)   Drop    Neurochem Inc.    Add    Caraco Pharmaceutical Laboratories Ltd.     Ophthalmology Index (HHZ)   Drop    Insite Vision Inc.    Add    King Pharmaceuticals     Patient Care Services Index (HHB)   Drop    Fresenius Medical Care (XETRA: FME.DE)   Add    Coventry Health Care Inc.     

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at http://www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company’s website at http://www.qedinternational.com/

QED International Associates Inc.

CONTACT: Ed Matluck, CEO, ematluck@qedinternational.com, or MichaelCarty, +1-212-953-4058, ematluck@qedinternational.com, both of QEDInternational

Web site: http://www.qedinternational.com/http://www.healthsharesinc.com/content/view/53/274